NYSE warns Cango (NYSE: CANG) on share price, gives six-month cure
Rhea-AI Filing Summary
Cango Inc. reported that it received a notice from the New York Stock Exchange stating its Class A ordinary shares no longer meet the NYSE continued listing price standard, because the 30 trading-day average closing price fell below US$1.00 per share as of March 9, 2026.
The company has a six-month cure period from March 10, 2026 to restore compliance by achieving both a closing price and 30-day average of at least US$1.00. If it fails, the NYSE may begin suspension and delisting procedures. Cango states that trading continues during this period and that the notice does not affect its operations, SEC reporting, credit agreements or other contractual obligations.
Positive
- None.
Negative
- Cango Inc. is below the NYSE’s US$1.00 minimum price standard, creating a defined risk of suspension and delisting if compliance is not restored within the six-month cure period.
Insights
NYSE price noncompliance introduces delisting risk but allows a defined cure window.
Cango Inc. has fallen below the NYSE’s minimum price standard, with its Class A shares averaging under US$1.00 over 30 trading days as of March 9, 2026. Under Section 802.01C, this triggers a formal noncompliance notice.
The company has a six-month Cure Period from March 10, 2026 to regain compliance by reaching at least US$1.00 both on the last trading day of a month and on the related 30-day average. Failing that, the NYSE would commence suspension and delisting procedures, which could shift trading to a less liquid venue.
Cango notes that its shares remain listed during the Cure Period and that the notice does not affect operations, SEC reporting duties, credit agreements, or other contracts. Management plans to monitor market conditions and is still considering options to address the deficiency, so actual outcomes will depend on future share-price performance and any actions the company undertakes.
Key Figures
Key Terms
continued listing standard regulatory
Cure Period regulatory
Section 802.01C regulatory
forward-looking statements regulatory
integrated energy solutions technical
distributed AI computing technical
FAQ
Why did Cango Inc. (CANG) receive a NYSE continued listing notice?
How long does Cango Inc. (CANG) have to regain NYSE price compliance?
What happens if Cango Inc. (CANG) fails to cure the NYSE price deficiency?
Does the NYSE notice affect Cango Inc.’s (CANG) operations or contracts?
What businesses does Cango Inc. (CANG) operate alongside its NYSE listing?
AI-generated analysis. How Rhea-AI works. Not financial advice.